Novartis India Limited (NOVARTIND.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 23.97B |
| Enterprise Value | 17.32B |
| P/E Ratio | 39.49 |
| PEG Ratio | -5.17 |
| Price/Sales Ratio | 10.39 |
| Price/Book Ratio | 4.5 |
| Enterprise/Revenue | 8.51 |
| Enterprise/EBITDA | 24.55 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.26 |
| Operating Margin | 0.26 |
| Return On Assets | 0.1 |
| Return On Equity | 0.12 |
| Revenue | 3.54B |
| Revenue/Share | 143.56 |
| Gross Profit | 1.33B |
| EBITDA | 941M |
| Net Income | 931.8M |
| Diluted EPS | 37.74 |
| Total Cash | 6.68B |
| Total Cash/Share | 270.52 |
| Total Debt | 32.1M |
| Total Debt/Equity | 0 |
| Current Ratio | 5.3 |
| Book Value Per Share | 331.35 |
| 52-Week Change | 49.16 |
| 52-Week High | 1,589.2 |
| 52-Week Low | 672.25 |
| Moving Average 50 Days | 1,192.37 |
| Moving Average 200 Days | 1,192.37 |
| Average Volume | 29,216 |
| Shares Outstanding | 24.69M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 25 |
| Trailing Annual Dividend Yield | 1.68 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |